Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-15

FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for mirtazapine from Sun Pharmaceutical Industries, Inc. (ANDA 076541). The action supports continued availability o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)